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Abstract
Asperparalines produced by Aspergillus japonicus JV-23 induce paralysis in silkworm (Bombyx mori) larvae, but the target
underlying insect toxicity remains unknown. In the present study, we have investigated the actions of asperparaline A on
ligand-gated ion channels expressed in cultured larval brain neurons of the silkworm using patch-clamp electrophysiology.
Bath-application of asperparaline A (10 mM) had no effect on the membrane current, but when delivered for 1 min prior to
co-application with 10 mM acetylcholine (ACh), it blocked completely the ACh-induced current that was sensitive to
mecamylamine, a nicotinic acetylcholine receptor (nAChR)-selective antaogonist. In contrast, 10 mM asperparaline A was
ineffective on the c-aminobutyric acid- and L-glutamate-induced responses of the Bombyx larval neurons. The fungal
alkaloid showed no-use dependency in blocking the ACh-induced response with distinct affinity for the peak and slowly-
desensitizing current amplitudes of the response to 10 mM ACh in terms of IC50 values of 20.2 and 39.6 nM, respectively.
Asperparaline A (100 nM) reduced the maximum neuron response to ACh with a minimal shift in EC50, suggesting that the
alkaloid is non-competitive with ACh. In contrast to showing marked blocking action on the insect nAChRs, it exhibited only
a weak blocking action on chicken a3b4, a4b2 and a7 nAChRs expressed in Xenopus laevis oocytes, suggesting a high
selectivity for insect over certain vertebrate nAChRs.
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Introduction
Asperparalines are alkaloids produced by Aspergillus japonicus JV-
23 when grown on ‘‘okara’’ media (soybean residue resulting from
tofu manufacturing). They are known to paralyze silkworm
(Bombyx mori) larvae when administered orally using artificial diets
[1]. Asperparalines A, B and C possess unique 3-spiro-succinimide
and cyclopent[f]indolizine moieties along with a N-methylamide
bridge [2] (Fig. 1). The unique structures of asperparalines have
prompted challenges for total synthesis [3], but their targets and
selectivity have not yet been elucidated.
It is presumed that the likely target of asperparaline A is the
nervous system or neuromuscular junction, since the compound
induces paralysis in the silkworm larvae. By applying whole-cell
patch-clamp electrophysiology to larval neurons of B. mori,w e
were able to record the neurotransmitter-evoked responses of
native ligand-gated ion channels and study the actions of
asperparaline A. Having detected a blocking action on nicotinic
acetylcholine receptors (nAChRs), we also investigated the actions
of asperparaline A on vertebrate (avian) a3b4, a4b2 and a7
nAChRs expressed in Xenopus laevis oocytes using two-electrode
voltage-clamp electrophysiology. We found that the fungal
metabolite specifically and non-competitively blocked the ACh-
induced response of the native nAChRs in the insect neurons, but
hardly affected receptors for c-aminobutyric acid (GABA) and L-
glutamate. Much weaker blocking actions of asperparaline A were
observed on 3 classes (a3b4, a4b2 and a7) of vertebrate (avian)
nAChRs, suggesting selectivity for invertebrate nAChRs.
Materials and Methods
Approval of this study and animal treatment
This study using living modified organisms (LMO) has been
approved by the committee of Kinki University for the
experiments involving the production of LMOs (ID number:
KDAS-16-015). We used an anesthetic tricaine to reduce the pain
of female frogs (Xenopus laevis) as much as possible when we
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18354removed oocytes from the frogs by referring to the U.K. Animals
(Scientific Procedures) Act, 1986.
B. mori neurons
Heads were dissected from last instar larvae of B. mori and
placed in a Ca
2+-free physiological saline solution of the
following composition: 135 mM NaCl, 3 mM KCl, 4 mM
MgCl2, 10 mM glucose and 10 mM HEPES (pH 7.3, adjusted
with NaOH), supplemented with 50 units ml
21 penicillin and
50 mgm l
21 streptomycin. The brains were isolated and
desheathed using fine forceps and then treated with 1.0 mg
ml
21 collagenase (Type IA, Sigma-Aldrich Japan, Tokyo, Japan)
dissolved in the Ca
2+-free saline for 30–40 min at room
temperature. After washing with the Ca
2+-free saline, the brains
were transferred to a Ca
2+-supplemented incubation saline of
the following composition: 135 mM NaCl, 3 mM KCl, 4 mM
MgCl2, 5 mM CaCl2,1 0m Mg l u c o s e ,1 0m Mt r e h a l o s ea n d
10 mM HEPES (pH 7.3, adjusted with NaOH) supplemented
with 10% fetal bovine serum and 50 units ml
21 penicillin and
50 mgm l
21 streptomycin. The neurons were dissociated by
gentle pipetting using a 1,000 ml micropipette tip, and the
resultant cell suspension was placed onto poly-D-lysine (Sigma-
Aldrich Japan, Tokyo, Japan)-coated coverslips which were
placed in a 35-mm diameter culture dish and left for 60 min.
The B. mori neurons were then incubated at 25uC for 18–36 h
before electrophysiology. All salines used in the cell culture were
filter sterilized.
Whole-cell patch-clamp electrophysiology
The whole-cell patch-clamp electrophysiology [4] was con-
ducted at 20–23uC. The recording electrodes (patch pipette)
were prepared from glass capillaries (PG150T-10, Harvard
Apparatus, Holliston, MA, USA) using a PE-83 puller
(Narishige, Tokyo, Japan). The patch pipette was filled with
an internal solution (100 mM KCl, 1 mM CaCl2,4m MM g C l 2,
20 mM sodium pyruvate, 10 mM EGTA and 10 mM HEPES
(pH 7.3, adjusted with Tris)). Only pipettes having a resistance
of 5–6 MV when filled with the internal solution were used for
experiments. Coverslips with neurons attached were carefully
transferred to the recording chamber (RC-16, Warner Instru-
ments, Hamden, CT, USA) and superfused continuously at 5 ml
min
21 with a physiological saline (135 mM NaCl, 3 mM KCl,
5m M C a C l 2,4 m MM g C l 2, 1 0m M g l u c o s e a n d 1 0m M
HEPES (pH 7.3, adjusted with NaOH)). The membrane
currents were recorded using an Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA, USA) and low-pass filtered
at 10 kHz using a four pole-Bessel filter. Data were stored on a
personal computer, for subsequent analysis, using a Digidata
1320A data acquisition system (Molecular Devices, Sunnyvale,
CA, USA). The holding membrane potential of the neuronal
membrane was 260 mV. The current-clamp method that keeps
the membrane current at zero was also used to examine the
effect of asperparaline A on the resting membrane potential of
the neuron. ACh, L-glutamate and GABA were applied to the
B. mori neurons using a U-tube; fipronil, mecamylamine and
asperparaline A were applied by either U-tube or bath-
application.
Expression of vertebrate nicotinic acetylcholine receptors
in X. laevis oocytes
Oocytes at stage V or VI of development were removed from
female X. laevis under anesthetic in 1.5 g l
21 tricaine [5,6,7].
Oocytes were then treated for 30–40 min at room temperature
with 2.0 mg ml
21 collagenase (Type IA, Sigma-Aldrich Japan,
Tokyo, Japan) dissolved in the Ca
2+-free standard oocyte saline
(SOS) of the following composition: 100 mM NaCl, 2 mM KCl,
1.8 mM CaCl2, 1 mM MgCl2 and 5 mM HEPES 5.0 (pH 7.6).
After washing in Ca
2+-free SOS to remove collagenase, the
follicle cell layer was manually removed using forceps, and
followed with the nuclear injection of 20 nl cDNAs of the chicken
nAChR subunits (a3, a4, a7, b2 and b3) in the pcDNA3.1 (+)
expression vector in distilled water (final concentration of each
cDNA: 0.1 ng nl
21). For a3b4a n da4b2, 1:1 mixtures of the a
and the non-a (b2a n db3) cDNA solution were injected into
oocytes. The injected oocytes were incubated at 18uCi nS O S
supplemented with penicillin (100 units ml
21), streptomycin
(100 mgm l
21), gentamycin (20 mgm l
21) and 2.5 mM sodium
pyruvate. Electrophysiology was conducted 3–5 days after
nuclear injection of cDNAs.
Two-electrode voltage-clamp (TEVC) electrophysiology
TEVC electrophysiology was performed at room temperature
(18–23uC). The X. laevis oocytes were secured in a Perspex
recording chamber that was continuously perfused with SOS (7–
10 ml min
21) as previously described [7,8]. Membrane currents
were recorded using a GENECLAMP 500B amplifier (Molecular
Devices, Sunnyvale, CA, USA) at a holding potential of
2100 mV. The electrodes were filled with 2 M KCl and had a
resistance of 1–5 MV when measured in SOS. Signals were
digitized using a Digidata 1200 data acquisition system
(Molecular Devices) and recorded using Clampex 9.0 (Molecular
Devices). Agonists were dissolved in SOS and were applied to
oocytes for 3–5 s, with an interval of 1–5 min between
applications, to ensure a full recovery from desensitization.
Asperparaline A (10 mM) was bath-applied to oocytes for 1 min
and then co-applied with ACh.
Analysis of electrophysiological data
The membrane current data were analyzed using Clampfit 9.2
(Molecular Devices, Sunnyvale, CA, USA). The concentration-
inhibition curves for asperparaline A were fitted with the following
equation, using Prism 4.03 (GraphPad Software, CA, USA):
Y~
Imax
1z10(½A -logIC50)_nH ð1Þ
where Y is the normalized response, Imax is the normalized
maximum response, IC50 (M) is the half maximal inhibitory
concentration, [A] is the logarithm of the concentration of
asperparaline A (M) and nH is the Hill coefficient. On the other
hand, the concentration-response curves for ACh were fitted with
Figure 1. Chemical structure of asperparaline A.
doi:10.1371/journal.pone.0018354.g001
Asperparaline A, a new antagonist of insect nAChRs
PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e18354Figure 2. Acetylcholine (ACh)-induced currents (A), the effects of blockers (mecamylamine and fipronil) on the ACh- (B), c-
aminobutyric acid (GABA) (C)- and L-glutamate (D)-induced currents and the actions of asperparaline A on the resting-state (E) and
neurotransmitter-evoked currents (F–H) in the silkworm (Bombyx mori) larval neurons. The holding potential was 260 mV. ACh (10 mM),
L-glutamate (30 mM) and GABA (30 mM) was applied for 2 s using the U-tube, whereas mecamylamine and fipronil were bath-applied for 1 min prior
to co-application with the agonists. In (E), asperparaline A was applied alone at 1 mM for 2 s using the U-tube, whereas in (F–H), it was bath-applied
for 1 min prior to co-application with neurotransmitters ACh (F), GABA (G) and L-glutamate (H). Note that both peak and slowly desensitizing current
amplitudes of the ACh-evoked response were blocked reversibly, selectively and almost completely by 1 mM asperparaline A (F).
doi:10.1371/journal.pone.0018354.g002
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Y~
Imax
1z10(logEC50-½A )_nH ð2Þ
where EC50 (M) is the half maximal effective concentration.
Chemicals
Fipronil and mecamylamine hydrochloride were purchased
from Sigma-Aldrich Japan (Tokyo, Japan). Asperparaline A
was obtained by purifying the okara broth of A. japonicus JV-23
as previously reported [1,2]. Stock solutions of fipronil,
mecamylamine and asperparaline A were prepared in DMSO
at a concentration of 10–100 mM and stored at 220uCu n t i l
use. These stock solutions were diluted with the physiological
saline described below. The final concentration (v/v) of
DMSO in test solutions was 0.1% or lower, which had no
adverse effect on the cellular response under investigation. Test
solutions of ACh, L-glutamate and GABA were prepared by
directly dissolving the stock solutions in saline immediately
prior to experiments.
Results
Membrane currents induced by three neurotransmitters
in B. mori larval brain neurons and actions of
asperparaline A on the membrane currents
Application of ACh (10 mM) resulted in a rapid inward current
at a holding potential of 260 mV with fast and slow desensitizing
phases. The ACh-induced currents were stably recorded using
intracellular (pipette) and extracellular (bath) solutions for 15 min
Figure 3. The effects of repeated application of ACh on the blocking action of asperparaline A. After recording the control response to
ACh at 10 mM, asperparaline A was continuously bath-applied at 30 nM, during which ACh was also applied at 10 mM for 2 s every minute using the
U-tube. (A) Traces of the ACh-induced current responses in the presence of 30 nM asperparaline A. (B) Normalized peak current amplitude of the ACh
responses recorded during the continuous application of asperparaline A. The peak current amplitude of each response was normalized by that of
the response recorded before the application of asperparaline A. Each plot represents the mean 6 standard error of the mean of 4 separate
experiments.
doi:10.1371/journal.pone.0018354.g003
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bath-applied 100 mM mecamylamine (n=4, Fig. 2B), a non-
competitive antagonist of nAChRs. Both GABA- and L-gluta-
mate-induced currents at the same holding potential were
attenuated by bath-applied 10 mM fipronil, a phenylpyrazole
insecticide known to block the chloride channels of GABA- and L-
glutamate-gated chloride channels in insects (Fig. 2C (n=4), D
(n=4)) [9,10].
To examine if asperparaline A activates any of ligand-gated ion
channels expressed in the silkworm neurons, it was applied alone
to the neurons at 10 mM. Asperparaline A had no effect on the
membrane current amplitude to clamp the membrane potential of
the B. mori larval neurons at 260 mV (n=4, Fig. 2E). In addition,
the compound was also ineffective on the resting membrane
potential of the neuron when tested under the current clamp
condition (n=5, data not shown). Hence, it was bath-applied for
1 min, prior to co-application for 2 s with ACh (10 mM), GABA
(30 mM) and L-glutamate (30 mM) (These neurotransmitter
concentrations are close to EC50), to explore any possible
antagonist actions on any ligand-gated ion channels present on
the neurons. Asperparaline A markedly and reversibly blocked the
ACh-induced current when applied at 1 mM (Fig. 2F). However,
the alkaloid barely affected the peak current amplitude of the
GABA (n=5, Fig. 2G)- and L-glutamate (n=5, Fig. 2H)-evoked
responses.
Effects of repeated application of ACh and pre-
application on the blocking action of asperparaline A
To examine whether the blocking action of asperparaline A was
use-dependent, asperparaline A was continuously bath-applied at
30 nM, during which ACh was also applied at 10 mM for 2 s every
minute. In such experiments, the blocking action was not
accelerated by repeated ACh-application over a 10 min period
(n=4, Fig. 3A, B).
Figure 4. Effects of pre-application on the antagonist action of
asperparaline A. (A) Asperparaline A was co-applied at 30 nM with
10 mM ACh for 2 s without pre-application, or applied for 1, 2 and 5 min
prior to co-application with 10 mM ACh. (B) The antagonist action of
asperparaline A with and without pre-application for 1, 2 and 5 min.
Each bar graph represents the mean 6 standard error of the mean
(n=4) of the peak current amplitude of the ACh-induced response
normalized by that taken before the application of asperparaline A. The
pre-application of asperparaline A significantly enhanced the antago-
nist action (p,0.05, One-way ANOVA, Tukey’s test), but there were no
significant differences in the blocking action between 1, 2, and 5 min
pre-applications.
doi:10.1371/journal.pone.0018354.g004
Figure 5. Concentration-inhibition curves for asperparaline A
in terms of attenuation of the responses to ACh of the
silkworm larval neurons. (A) The ACh-induced responses recorded
before and after bath-application of asperparaline A for 1 min prior to
co-application with 10 mM ACh. The peak and slowly desensitizing
currents are indicated by ‘‘a’’ and ‘‘b’’, respectively. (B) Concentration-
inhibition curves for asperparaline A. Data were normalized to the
maximum response to ACh (10 mM). Each plot represents the mean 6
the standard error of the mean of 4 experiments. The concentration-
inhibition curves were obtained by fitting the data to Eq. (1) (see
Materials and Methods). The pIC50 (=log(1/IC50) values for the peak and
slowly desensitizing currents were 7.6960.02 (n=4, IC50=20.2 nM) and
7.4060.04 (n=4, IC50=39.6 nM), respectively. These two values are
significantly different (p,0.05, t-test).
doi:10.1371/journal.pone.0018354.g005
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pre-application was significantly lower than when pre-applied
(n=4, p,0.05, one-way ANOVA, Tukey’s test, Fig. 4A, B). Thus,
the effects of three different pre-application times (1, 2 and 5 min)
on the blocking action were examined. No significant difference in
the blocking action was observed between the pre-application
times tested (n=4, Fig. 4A, B).
Mode of blocking action of asperparaline A on B. mori
nicotinic acetylcholine receptors
It has been shown that a neonicotinoid insecticide imidacloprid
differentially modulated two phases (desensitizing and non-desen-
sitizing) of the ACh-induced currents in the American cockroach
neurons [11]. Hence we examined whether asperparaline A
differentially blocks the peak and slowly desensitizing currents.
Using the 1 min pre-application protocol, the pIC50 (=log(1/IC50)
of asperparaline A for the peak and slowly desensitizing current
amplitudes were determined to be 7.6960.02 (n=4, IC50=
20.2 nM) and 7.4060.04 (n=4, IC50=39.6 nM), respectively
(Fig. 5). A significant difference was observed between the two
IC50 values ((p,0.05, t-test).
To explore further the blocking action, the concentration-
response relationship of ACh was measured in the presence and
absence of 100 nM asperparaline A (Fig. 6) using the 1 min pre-
application protocol for the alkaloid application. It reduced the
normalized maximum response to ACh to approximately
25.7%, while scarcely influencing pEC50 (with 100 nM asper-
paraline A, 4.9860.14, n=4, EC 50=10.5mM; without asper-
paraline A, 4.9460.04, n=7,EC 50=11. 4 mM). No significant
shift in EC50 was observed by the presence of 100 nM
asperparaline A.
Actions of asperparaline A on vertebrate nicotinic
acetylcholine receptors expressed in X. laevis oocytes
Asperparaline A was tested on the chicken a3b4, a4b2a n d
a7 nAChRs expressed in X. laevis oocytes (Fig. 7). When tested
alone, the alkaloid showed no agonist action on these three
nAChRs, at concentrations up to 10 mM (data not shown). Thus
it was bath-applied at 10 mM for 1 min prior to co-application
with 100 mM ACh. It reduced the peak current amplitude of the
ACh-induced response of a3b4 nAChR by 33.463.3% (n=3,
Fig. 7A), while barely influencing the amplitudes of the
responses to ACh of the a4b2( n = 4 ,F i g .7 B )a n da7( n = 3 ,
Fig. 7C) nAChRs.
Discussion
Since the discovery of asperparaline A in 1997, its target has
remained unknown. Here we have for the first time tested
asperparaline A on ligand-gated ion channels present on the
silkworm larval neurons using patch-clamp electrophysiology.
Asperparaline A was found to selectivity reduce the ACh-
induced currents (Fig. 2F) that were also blocked by mecamyl-
amine (Fig. 2B). In addition, it barely affected the GABA
(Fig. 2G)- and L-glutamate (Fig. 2H)-induced currents, indicat-
ing a specific antagonist action on nAChRs present in the
neuron. In insects, however, cation-permeable, ionotropic
glutamate receptors mediate fast-acting neuromuscular trans-
mission and are targeted by several venoms [12]. As such, tests
of asperparaline A on this type of ligand-gated ion channels are
of importance to ensure that the toxicity of this compound to the
silkworm larvae is the result of the selective antagonist action on
nAChRs.
Asperparaline A was not an open channel blocker of the
nAChRs because there was no evidence of use-dependency in the
blocking action (Fig. 3). The ACh-induced currents consisted of
fast and slow desensitizing phases (Figs. 2–5), which may reflect
the presence of several receptor subtypes as reported for other
insect neurons [11]. The peak and slowly-desensitizing ACh-
induced currents showed different asperparaline-sensitivity
(Fig. 5). Given that the isoforms of all the silkworm nAChR
subunits resulting from splicing and RNA editing have been
elucidated [13], it will be of interest in future to examine the
affinity of asperparaline A for nAChR subtypes. Nonetheless, it is
at present difficult to express functional and robust nAChRs
consisting of only insect receptor subunits including those of the
silkworm in heterologous cells, which should be resolved
primarily.
We examined the effects of asperparaline A on the concentra-
tion-response curve for ACh. The alkaloid (100 nM) reduced the
normalized maximum response to ACh, while scarcely influencing
EC50 (Fig. 6), suggesting that ACh and asperparaline A do not
compete for the same binding site at nAChRs.
To investigate whether asperparaline A is a selective antagonist
of insect nAChRs, or equally effective on vertebrate nicotinic
AChRs, its actions on the chicken a3b4, a4b2 and a7 nAChRs
expressed in X. laevis oocytes were investigated using two-electrode
voltage-clamp electrophysiology. Although a3b4 nAChR showed
higher asperparaline A-sensitivity than others, the blocking effect
was only 33.4% of the control response at 10 mM, a concentration
about 250–500-fold higher than the IC50 for the B. mori nAChRs
(Fig. 7). Moreover, the blocking action on a4b2 and a7 was very
weak at this concentration, suggesting a high selectivity for insect
over certain vertebrate (avian) nAChRs. We cannot of course rule
out that other vertebrate nAChRs may show higher sensitivity to
this alkaloid than a3b4, a4b2 and a7 [14].
Figure 6. Effects of asperparaline A on the concentration-
response curve for ACh in the silkworm larval neurons. The
ACh-induced responses were measured at various concentrations in the
presence and absence of 100 nM asperparaline A. The concentration-
response curves were obtained by fitting the data to Eq. (2) (see
Materials and Methods). The pEC50 (=log(1/EC50)) values determined in
the presence and absence of asperparaline A were 4.9860.10 (n=4,
EC50=10.5 mM) and 4.9460.04 (n=7, EC50=11.4 mM), respectively. No
significant shift in EC50 was observed by the application of asperpara-
line A.
doi:10.1371/journal.pone.0018354.g006
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asperparaline A from A. japonicus JV-23 targets the nAChRs
among the ligand-gated ion channels expressed by B. mori neurons,
offering an explanation, at least in part, for the paralysis exhibited
by silkworm larvae exposed to this compound. The asperparaline
A acts on native B. mori nAChRs as a non-competitive antagonist,
and is highly selective to insect (silkworm), over vertebrate
(chicken), nAChRs. Future research should focus on elucidation
of the mechanism of the selectivity, which may pave a new way for
novel pest control chemicals.
Author Contributions
Conceived and designed the experiments: KM HH. Performed the
experiments: KH SK SF KM. Analyzed the data: KH SK KM.
Contributed reagents/materials/analysis tools: HH. Wrote the paper:
KH HH KM.
References
1. Hayashi H, Nishimoto Y, Nozaki H (1997) Asperparaline A, a new paralytic
alkaloid rom Aspergillus japonicus JV-23. Tetrahedron Lett 38: 5655–
5658.
2. Hayashi H, Nishimoto Y, Akiyama K, Nozaki H (2000) New paralytic alkaloids,
asperparalines A, B and C, from Aspergillus japonicus JV-23. Biosci Biotechnol
Biochem 64: 111–115.
Figure 7. Effects of asperparaline A on the ACh-induced responses of chicken a3b4 (A), a4b2 (B) and a7 (C) nAChRs expressed in
Xenopus laevis oocytes. After three successive control applications of ACh, 10 mM asperparaline A was continuously bath-applied and then co-
applied with 100 mM ACh. Asperparaline A blocked the ACh-response of a3b4 nAChR by 33.463.3% (n=3), whereas it scarcely influenced the
response of a4b2 (n=4) and a7 (n=3) nAChRs.
doi:10.1371/journal.pone.0018354.g007
Asperparaline A, a new antagonist of insect nAChRs
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e183543. Williams RM, Cox RJ (2003) Paraherquamides, brevianamides, and asperpar-
alines: laboratory synthesis and biosynthesis. An interim report. Acc Chem Res
36: 127–139.
4. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-
clamp techniques for high-resolution current recording from cells and cell-free
membrane patches. Pflu ¨gers Arch 391: 85–100.
5. Matsuda K, Shimomura M, Kondo Y, Ihara M, Hashigami K, et al. (2000) Role
of loop D of the a7 nicotinic acetylcholine receptor in its interaction with the
insecticide imidacloprid and related neonicotinoids. Br J Pharmacol 130:
981–986.
6. Matsuda K, Buckingham SD, Freeman JC, Squire MD, Baylis HA, et al. (1998)
Effects of the a subunit on imidacloprid sensitivity of recombinant nicotinic
acetylcholine receptors. Br J Pharmacol 123: 518–524.
7. Shimomura M, Yokota M, Ihara M, Akamatsu M, Sattelle DB, et al. (2006) Role
in the selectivity of neonicotinoids of insect-specific basic residues in loop D of
the nicotinic acetylcholine receptor agonist binding site. Mol Pharmacol 70:
1255–1263.
8. Hirata K, Ishida C, Eguchi Y, Sakai K, Ozoe F, et al. (2008) Role of a serine
residue (S278) in the pore-facing region of the housefly L-glutamate-gated
chloride channel in determining sensitivity to noncompetitive antagonists. Insect
Mol Biol 17: 341–350.
9. Ikeda T, Zhao X, Kono Y, Yeh JZ, Narahashi T (2003) Fipronil modulation of
glutamate-induced chloride currents in cockroach thoracic ganglion neurons.
Neurotoxicology 24: 807–815.
10. Zhao X, Yeh JZ, Salgado VL, Narahashi T (2004) Fipronil is a potent open
channel blocker of glutamate-activated chloride channels in cockroach neurons.
J Pharmacol Exp Ther 310: 192–201.
11. Salgado VL, Saar R (2004) Desensitizing and non-desensitizing subtypes of
alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in cockroach
neurons. J Insect Physiol 50: 867–879.
12. Strømgaard K, Jensen LS, Vogensen SB (2005) Polyamine toxins: development
of selective ligands for ionotropic receptors. Toxicon 45: 249–254.
13. Shao YM, Dong K, Zhang CX (2007) The nicotinic acetylcholine receptor gene
family of the silkworm, Bombyx mori. BMC Genomics 8: 324.
14. Millar NS, Gotti C (2009) Diversity of vertebrate nicotinic acetylcholine
receptors. Neuropharmacology 56: 237–246.
Asperparaline A, a new antagonist of insect nAChRs
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18354